Navigation Links
Golden Meditech Increases Stakes in Cordlife, Largest Cord Blood Bank Operator in Southeast Asia
Date:10/28/2008

HONG KONG, Oct. 28 /Xinhua-PRNewswire-FirstCall/ -- Golden Meditech Company Limited ("Golden Meditech" or "the Group", HKEx: 8180) is pleased to announce today that the Group has increased shareholding in Cordlife, Southeast Asia's largest umbilical cord blood bank operator listed on Australia Stock Exchange, to 18.9%, and became the latter's single largest shareholder at a consideration of 2.4 million Australian Dollars (equivalent to HK$12 million).

Mr. KAM Yuen, Chairman of Golden Meditech, explained that Cordlife not only owns the exclusive license of operating cord blood bank services in Indonesia and the only one operating license issued to a foreign entity in India, but also has operations in Hong Kong, Macau, Australia, Singapore, Thailand, the Philippines, etc.

Mr. KAM said that raising the strategic ownership of shareholding in Cordlife has not only extended the arms of Group's cord blood bank business beyond China, to the rest of the world's most-populated countries in Asia- Pacific regions, but also helps improve the success rate of HLA (human leukocyte antigen) marching in Asia as well, which can benefit a large number of patients in need of stem cell transplants.

He emphasized that along with the further development in India, Indonesia and other Asian states, where the cord blood bank services just began to gain the spotlights, Asia will soon become the world's largest market of cord blood bank services.

According to the statistics of the United Nations Population Division, almost 61% of the world's population, approximately 3.87 billion people reside in Asia. Besides, Asia has about 80 million newborn babies a year, who are the target customers of the cord blood bank services.

He said that despite the ongoing financial crisis that has induced extreme volatility of the capital market, healthcare industry on its own is less affected by such business cycles. The management will cautiously look into investment opportunities that will strengthen all key operations.

This transaction was completed at a time when the stock prices and the exchange rates of Australian dollar were in our favor. It is considered conducive to not only the further development of the Group's cord blood bank operations, but also the enhancement of shareholders' value and returns.

For inquiry, please kindly contact:

Investor Relations Division

Golden Meditech Company Limited

Tel: +852-3605-8138

Fax: +852-3605-8181

Email: ir@goldenmeditech.com


'/>"/>
SOURCE Golden Meditech Company Limited
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Golden Corrals Good Health Recipe for the Flu Season
2. National Energy Services Receives Repeat Orders From Golden Living and Cathedral Rock Skilled Nursing Facilities
3. Giving Back to the Community Golden Corral Style
4. Golden Doctor of Chiropractic Elected President of the Colorado Chiropractic Association
5. Kaiser Permanente and Golden State Warriors Team Up to Fight Childhood Obesity
6. Histochemistry is the golden standard in the diagnosis of carcinosarcomas
7. Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross and Lifetime Television Deliver 20 Million Online Petition Signatures to Capitol Hill to Urge Congress to Stop Drive-Through Mastectomies
8. Author Elizabeth Golden and Dancer Sarah Patellos to Serve as National Spokespersons for the National Scoliosis Foundation
9. American Airlines Honors Flight Attendants at Golden Heart Awards Ceremony
10. Golden State Medical Supply Selects IBM Technology to Comply With California Prescription Drug Pedigree Regulations
11. Golden Rainbow Takes a Musical Journey for Its 22nd Annual Ribbon of Life Production Show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... As health ... medicine known as “patient engagement.” The patient is doing more than filling out a ... , “There is an increasing emphasis in health care and research on the ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along ... updates for the primary prevention of cardiovascular diseases during the 15th Annual ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Ellevate Network, ... in business to advocate for action towards gender equality at their inaugural Summit in ... around the globe, and reached a social audience of over 3 million. To watch ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “The Journey: From ... every danger possible to save lost souls in the Philippines. “The Journey: From the ... is a dedicated teacher of the Bible. She has taught all ages and currently ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... Oct. 12, 2017 AVACEN Medical , Inc. ... with their  2017 New Product Innovation Award for Its ... primary and secondary medical device market research by Frost & ... first-to-market OTC, drug-free pain relief product, the AVACEN 100, offers ... treating fibromyalgia widespread pain. ...
(Date:10/12/2017)... , Oct. 12, 2017 West Pharmaceutical ... innovative solutions for injectable drug administration, today announced that ... market opens on Thursday, October 26, 2017, and will ... and business expectations at 9:00 a.m. Eastern Time. To ... 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ... on fulfilling the promise of precision medicine, today announced ... joined Caris, Precision Oncology Alliance™ (POA) as its 17 ... centers, the St. Jude Crosson Cancer Institute will help ... the use of tumor profiling, making cancer treatment more ...
Breaking Medicine Technology: